Vendor, Boston, MA
Vedanta Biosciences, Inc.
UEI C91JJXT9QND5, CAGE 6DGY3
1 award and $63,000,000 obligated between February 14, 2024 and July 21, 2026, 100% under full and open competition, against 1.0 offers on average where reported.
Sells to
Awarding agencies by dollars.
| Office of Assistant Secretary for Preparedness and Response | $63,000,000 |
Industries
NAICS on the awards, by dollars.
| Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714 | $63,000,000 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 1 |
| Definitive Contract | 1 |
Hear when Vedanta Biosciences, Inc. wins an award and when a contract it holds is about to end.Follow it
Contracts ending soon
None of Vedanta Biosciences, Inc.'s contracts with a published end date ends in the next 19 months.
Competes with
Vendors selling research and development in biotechnology (except nanobiotechnology) to Office of Assistant Secretary for Preparedness and Response, by dollars.
| Advanced Technology InternationalSummerville, SC | $2,764,576,471 |
| Albert B. Sabin Vaccine Institute, Inc. (The)Washington, DC | $356,898,734 |
| Amgen USA Inc.Thousand Oaks, CA | $345,705,117 |
| Start2 Group, Inc.Cambridge, MA | $227,139,021 |
| Siga Technologies, Inc.New York, NY | $177,835,284 |
| Shionogi Inc.Florham Park, NJ | $156,109,904 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75A50120C00177Definitive Contract, February 14, 2024, Full and Open Competition, 1 offers | Barda - Aspr / Daappo / Barda DCMAOffice of Assistant Secretary for Preparedness and Response | EO14042 to Develop Medical Countermeasures (Mcms) That Treat Antibiotic Resistant Infections.NAICS 541714, PSC AZ13 | $63,000,000 |
- Places of performance
- Massachusetts
- Product and service codes
- AZ13
- Transactions
- 10 across 1 awards